2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 24, C07H 1900

Patent

active

049084402

ABSTRACT:
There are disclosed novel 2',3'-dideoxy-2'-fluoronucleosides and 2'-3'-dideoxy-2',3'-didehydro-2'-fluoronucleosides and processes for their preparation. The compounds so produced exhibit therapeutically useful antiviral and, more particularly, anti-HIV effects.

REFERENCES:
A. Townsend & S. Tipson, Editors, Nucleic Acid Chemistry, Part I, p. 299 (John Wiley & Sons, New York).
DDI Promising in Clinical Trials, Scrip, 6/21/89, p. 1422.
Mitsuya et al., Proc. Natl. Acad. Sci., USA, 83 (1986), pp. 1911-1915.
Baba et al., Biochem and Biophys. Res. Comm., 142, No. 1, 1987, pp. 128-134.
Yarchoan et al., The Lancet, Jan. 16, 1988, pp. 76-80.
Glinski et al, J. Org. Chem., 38, No. 25, pp. 4299-4308 (1973).
Hampton et al, J. Med. Chem., 22, No. 6, pp. 621-631 (1972).
Lin et al, Biochemical Pharmacology, 36, No. 3, pp. 311-316 (1987).
Fauci, Proc. Natl. Aca. Sci., USA, 83, pp. 9278-9283 (1986), Washington Post, Jul. 25, 1988.
Herdewijn et al, The Chemical Abstracts, 107:176403a (1987).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-51821

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.